Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Conditions: Lower Urinary Tract Symptoms; Benign Prostatic Hyperplasia Interventions: Drug: Tamsulosin 0.2mg + Solifenacin 5mg; Drug: Tamsulosin 0.2mg + Placebo(Solifenacin) Sponsor: Jeil Pharmaceutical Co., Ltd. Recruiting - verified November 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | VESIcare